-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease is associated with progressive impairment of memory, language, orientation, and other cognitive skills.
In a new paper published in "Light Science & Application" (Light Science & Application), a report led by Professor Wei Xunbin from the Med-X Institute and School of Biomedical Engineering, Shanghai Jiaotong University, and the Department of Biomedical Engineering, Peking University Group of scientists and colleagues used a specific stimulation pattern to treat AD mouse models with PBM
The device consists of a cavity and a light emitting diode (LED) array
After light therapy, they explored the effects of light on mice at different stages of AD
"Our results prove the effects of 1070 nanometer light on microglia regulation and cerebral blood vessels at different stages of AD, and provide valuable insights into the mechanism of 1070 nanometer light treatment of AD
DOI
10.